MedPath

SANDOZ GEFITINIB

SANDOZ GEFITINIB

Approved
DIN Number

02487748

Drug Class

Human

Market Date

Jun 26, 2019

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02487748
AIG Number0149783001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EB01 GEFITINIB
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

GEFITINIBActive
Strength: 250 MG
Monograph: GEFITINIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.